Literature DB >> 1380167

Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.

R L Woltjer1, T J Lukas, J V Staros.   

Abstract

We have recently developed a kinetically controlled, step-wise affinity cross-linking technique for specific, high-yield, covalent linkage of murine epidermal growth factor (mEGF) via its N terminus to the EGF receptor. EGF receptor from A431 cells was cross-linked to radiolabeled mEGF (125I-mEGF) by this technique and the 125I-mEGF-receptor complex was purified and denatured. Tryptic digestion of this preparation gave rise to a unique radiolabeled peptide that did not comigrate with trypsin-treated 125I-mEGF in SDS/Tricine gels but that could be immunoprecipitated with antibodies to mEGF. The immunoprecipitated peptide was isolated by electrophoresis in SDS/Tricine gels, eluted, and sequenced. The sequence was found to correspond to that of a tryptic peptide of the EGF receptor beginning with Gly-85, which is in domain I, a region N terminal to the first cysteine-rich region of the receptor. Selective loss of signal in the 17th sequencing cycle suggests that the point of attachment of N-terminally modified 125I-mEGF to the receptor is Tyr-101. The data presented here provide identification by direct protein microsequencing of a site of interaction of EGF and the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380167      PMCID: PMC49799          DOI: 10.1073/pnas.89.16.7801

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.

Authors:  I Lax; F Bellot; A M Honegger; A Schmidt; A Ullrich; D Givol; J Schlessinger
Journal:  Cell Regul       Date:  1990-01

2.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

3.  Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation.

Authors:  A Basu; M Raghunath; S Bishayee; M Das
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

4.  Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site.

Authors:  D G Wu; L H Wang; G H Sato; K A West; W R Harris; J W Crabb; J D Sato
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

Review 5.  Epidermal growth factor and its receptor.

Authors:  G N Gill; P J Bertics; J B Santon
Journal:  Mol Cell Endocrinol       Date:  1987-06       Impact factor: 4.102

6.  Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling.

Authors:  I Lax; W H Burgess; F Bellot; A Ullrich; J Schlessinger; D Givol
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

7.  Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain.

Authors:  I Lax; A K Mitra; C Ravera; D R Hurwitz; M Rubinstein; A Ullrich; R M Stroud; J Schlessinger
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

8.  Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide.

Authors:  U Murthy; A Basu; U Rodeck; M Herlyn; A H Ross; M Das
Journal:  Arch Biochem Biophys       Date:  1987-02-01       Impact factor: 4.013

9.  Epidermal growth factor binding induces a conformational change in the external domain of its receptor.

Authors:  C Greenfield; I Hiles; M D Waterfield; M Federwisch; A Wollmer; T L Blundell; N McDonald
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

10.  Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.

Authors:  I Lax; F Bellot; R Howk; A Ullrich; D Givol; J Schlessinger
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  6 in total

1.  The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor.

Authors:  A E Lenferink; A D De Roos; M J Van Vugt; M L Van de Poll; E J Van Zoelen
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

2.  Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.

Authors:  R N Jorissen; V C Epa; H R Treutlein; T P Garrett; C W Ward; A W Burgess
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

3.  A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Authors:  R Nishikawa; X D Ji; R C Harmon; C S Lazar; G N Gill; W K Cavenee; H J Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

4.  Molecular analysis of the Drosophila EGF receptor homolog reveals that several genetically defined classes of alleles cluster in subdomains of the receptor protein.

Authors:  R Clifford; T Schüpbach
Journal:  Genetics       Date:  1994-06       Impact factor: 4.562

5.  Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.

Authors:  Richard A Stein; James V Staros
Journal:  BMC Evol Biol       Date:  2006-10-06       Impact factor: 3.260

6.  A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.

Authors:  T Rajkumar; W J Gullick
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.